Neutrophil gelatinase-associated lipocalin (NGAL) is a novel 25-kD protein of human neutrophils, that is in part covalently complexed with neutrophil gelatinase. However, both NGAL and gelatinase exist mainly in forms not associated with each other. An explanation for this phenomenon might be that the unassociated proteins reside in different subcellular compartments. The aim of the present study was to determine the subcellular localization of NGAL. An enzyme-linked immunosorbent assay (ELSA) for NGAL was developed using specific anti-NGAL antibodies. The assay was applied on subcellular fractions of neutrophils obtained after centrifugation of a postnuclear supernatant on a two-layer Percoll gradient. The distribution profile of NGAL was found to colocalize strictly with the distribution profile of lactoferrin. This was confirmed by im-HE EXISTENCE OF distinct granule populations that are differentially mobilized is a prerequisite for the gradual activation of the human neutrophil.' In the process of diapedesis, neutrophil gelatinase may play a major role in degradation of type IV collagen of basement membrane surrounding end~thelium.',~ The subcellular localization of this metalloproteinase has been intensively investigated over the recent years4-' To address this subject, we purified neutrophil gelatinase and found that the pure protein is in part covalently complexed with a novel 25-kD protein. This protein was purified and its amino acid sequence determined. We have named the protein neutrophil gelatinaseassociated lipocalin (NGAL).9 As the name implies, this protein is a member of the lipocalin family, a family of proteins that share a common compact tertiary structure with a central hydrophobic This core enables the proteins to bind small lipophilic substances, eg, r e t i n~l . '~, '~, '~ Another characteristic of the lipocalins is their tendency to associate covalently with other proteins in line with the association of NGAL with gelatina~e.'~.'~ NGAL can be purified in both a monomeric and dimeric form. Furthermore, Western blotting of a postnuclear supernatant of neutrophils, electrophoresed under nonreducing conditions, showed that NGAL exists mainly in forms not associated with gelatinase, namely as the monomeric and homodimeric forms in addition to a 68-kD form.' The nature of the 68-kD form is yet unknown. Likewise, gelatinase exists mainly in a monomeric and homodimeric form.' Thus, both NGAL and gelatinase exist predominantly in forms not associated with each other. An explanation for this phenomenon could be that they are partly segregated, residing in different subcellular compartments of the neutrophil.
HE EXISTENCE OF distinct granule populations that
are differentially mobilized is a prerequisite for the gradual activation of the human neutrophil.' In the process of diapedesis, neutrophil gelatinase may play a major role in degradation of type IV collagen of basement membrane surrounding end~thelium.',~ The subcellular localization of this metalloproteinase has been intensively investigated over the recent years4-' To address this subject, we purified neutrophil gelatinase and found that the pure protein is in part covalently complexed with a novel 25-kD protein. This protein was purified and its amino acid sequence determined. We have named the protein neutrophil gelatinaseassociated lipocalin (NGAL).9 As the name implies, this protein is a member of the lipocalin family, a family of proteins that share a common compact tertiary structure with a central hydrophobic This core enables the proteins to bind small lipophilic substances, eg, r e t i n~l . '~, '~, '~ Another characteristic of the lipocalins is their tendency to associate covalently with other proteins in line with the association of NGAL with gelatina~e.'~.'~ NGAL can be purified in both a monomeric and dimeric form. Furthermore, Western blotting of a postnuclear supernatant of neutrophils, electrophoresed under nonreducing conditions, showed that NGAL exists mainly in forms not associated with gelatinase, namely as the monomeric and homodimeric forms in addition to a 68-kD form. ' The nature of the 68-kD form is yet unknown. Likewise, gelatinase exists mainly in a monomeric and homodimeric form.' Thus, both NGAL and gelatinase exist predominantly in forms not associated with each other. An explanation for this phenomenon could be that they are partly segregated, residing in different subcellular compartments of the neutrophil.
Using our specific antigelatinase antibodies and antibodies against lactofemn, we have been able to confirm the existence of subpopulations within the peroxidase negative granules, one population being gelatinase granules, These contain most ofthe gelatinase but hardly any lact~ferrin.'~.'' These granules are the lightest and comprise 25% of peroxidase-negative granules. Another subpopulation ( 15% ofperoxidase-negative granules) contains lactofenin but no g&-T Blood, Vol83, No 3 (February l ) , 1994 : pp 799-807 munogold double-labeling of frozen thin sections of neutrophils that showed a high degree of colocalization of NGAL and lactoferrin, and by exocytosis experiments, which showed lactoferrin, vitamin B,,-binding protein, and NGAL to be similarly released upon stimulation. Therefore, NGAL is a novel matrix protein of specific granules and thus partly segregated from gelatinase, the major part of which is located in a separate compartment, the gelatinase granules. An ELSA specific for the NGAL/gelatinase complex was developed and the subcellular distribution and release of this complex was determined. The distribution and mobilization of the complex allowed us to confirm the existence of differentially mobilized granule subpopulations among peroxidase negative granules. 0 l994 by The American Society of Hematology.
tinase, and are the most dense. The remaining granules (60%) are of intermediate density and contain both lactoferrin and gelatinase. The latter two populations constitute the specific granules. Localization of NGAL in specific granules would imply a spatial segregation of NGAL and of the major part of gelatinase and might explain the existence of both unassociated and associated forms of these two proteins.
To test this hypothesis we have developed enzyme-linked immunosorbent assays (ELISAs) for NGAL and for the NGAL/gelatinase complex and applied these on subcellular fractions obtained after nitrogen cavitation of human neutrophils followed by centrifugation of the postnuclear supernatant on a two-layer Percoll gradient. These experiments are corroborated by exocytosis experiments and furthermore by immunogold double-labeling of frozen thin sections using antibodies against NGAL and lactofemn, or NGAL and gelatinase. sodium citrate, 126 mmol/L glucose. An equal volume of 2% Dextran T-500 (Pharmacia, Uppsala, Sweden) in saline was added to facilitate the sedimentation of red blood cells. The leukocyte-rich supernatant was collected after 45 minutes. The cells were pelleted by centrifugation at 200g for IO minutes, and resuspended in saline for subsequent centrifugation on Lymphoprep (Nygaard, Oslo, Norway) at 400g for 30 minutes to remove mononuclear cells.I8 Remaining erythrocytes were lysed by hypotonic shock for 30 seconds in ice-cold water. Tonicity was restored by addition ofan equal volume of 1.8% NaCI. The cells were then washed once in saline followed by resuspension in the desired buffer. All steps were performed at 4"C, except for sedimentation of red blood cells (room temperature).
MATERIALS AND METHODS

Isolation
Release studies. Cells were resuspended at 3 X 107/mL in I30 mmol/L NaCI, 5 mmol/L KC1, I .27 mmol/L MgCl, 0.95 mmol/L CaCI, 5 mmol/Lglucose, 10 mmol/L NaH2P04/Na2HP04, pH 7.4. Control cells were either kept on ice or incubated at 37°C for 20 minutes. For stimulation, 1 mL ofcell suspension was preincubated at 37°C for 5 minutes followed by addition of the stimulus at the indicated concentration. Incubation was terminated after NG24L untibodies. Antibodies were obtained as described.' In short, rabbits were immunized with purified neutrophil gelatinase. The subsequently generated antibodies reacted with both gelatinase and NGAL. NGAL was isolated in a form not associated with gelatinase by gel filtration of material exocytosed from neutrophils after stimulation by PMA. This material was coupled to CNBr-activated Sepharose (Pharmacia), and the antibodies were applied to this column. Antibodies with specificity for NGAL bound to the column and were subsequently eluted. These antibodies were biotinylated as described.20
NGA L ELISA. NGAL was assayed by an ELISA using 96-well flat-bottom immunoplates (Nunc, Roskilde, Denmark). The plates were coated overnight with anti-NGAL antibodies, diluted 1:2,000 in carbonate buffer (50 mmol/L Na2C03/NaHC03, pH 9.6). Additional binding sites were blocked by incubation with 200 FL/well of dilution buffer (0.5 mol/L NaCI, 3 mmol/L KCI. 8 mmol/L Na2HP04/KH2P04, pH 7.2, 1% bovine serum albumin, I% Triton X-100). Samples were then applied, followed by addition of biotinylated anti-NGAL antibody diluted I :2,000 and by addition ofavidin-peroxidase (P347, Dakopatts, Glostrup, Denmark) diluted 1: 2,000. All incubations were performed in 100 pL/well for 1 hour unless stated otherwise. Color was developed during a 30-minute Fraction number were fixed in 2% paraformaldehyde and 0.05% glutaraldehyde, embedded in sucrose, and cryosectioned as described in Materials and Methods. The polyclonal antibody against NGAL was applied in 1 :l00 dilution, followed by protein A -l 0 gold. Note that many granules resembling specific granules (SG) contain label, whereas the more extracted azurophil granules (AG) do not. Original magnification X 45,000. (b) In this preparation, cells were fixed as above, reacted enzymatically for peroxidase, then frozen in sucrose, sectioned, and subsequently stained on frozen thin sections as described above. In this preparation, the azurophil granules (AG) are identified by their electron dense peroxidase reaction product. These do not contain label as opposed to the peroxidase negative granules (SG). Original magnification X 42,000. (c) Portion of neutrophil prepared as in (a) A major problem in trying to localize and quantitate NGAL is the fact that this relatively low molecular-weight protein seems to spill out of the granules. Whereas the location in the specific granules (SG) is concordant with the localization seen in (a) and (b), many gold particles can be seen outside of the cell, in the cytoplasm, in a vacuole, and on the nucleus. Original magnification X 56,000. Table 1 ). Original magnification X 71,400. incubation in 0. I mol/L sodium phosphate, 0. I mol/L citric acid buffer, pH 5.0 containing 0.04% +phenylenediamine and 0.03% HzOt (100 pL/well), and stopped by addition of 100 pL 1 mol/L H2S04. The plates were washed three times in washing buffer (0.5 mol/L NaCI, 3 mmol/L KCI, 8 mmol/L Na2HP04/KH2P04, pH 7.2, 1% Triton X-100) between all steps. An additional wash in sodium phosphate citric acid buffer was included before color development. Absorbance was read at 492 nm in a Multiscan Plus EL-ISA-reader (Labsystems, Helsinki, Finland). A standard of purified monomeric NGAL ranging from 0.086 to 5.5 ng/mL was used. Samples were diluted from 100-to 10,000-fold in dilution buffer. All steps were performed at room temperature.
NGAL/gelatinase-complex ELISA. All procedures were as described for NGALELISA, with the following exceptions: Anti- The upper panel shows labeling pattern after double labeling for NGAL and lactoferrin, whereas the lower panel shows labeling pattern after double labeling for NGAL and gelatinase. Labeling was performed as described in Materials and Methods, and as described in legends to Figs 4 and 5.
NGAL antibodies were used as catching antibody in a dilution of 1: 1 ,ooO; biotinylated affinity-purified antigelatinase antibodies were employed as detecting antibody (dilution 1: I,OOO), followed by avidin-peroxidase (dilution 1:2,000). Granule matrix proteins were prepared by Triton X-1 14 phase separation" of a 6 band from subcellular fractionation of 2 X IO9 neutrophils and served as a standard. Highest standard was arbitrarily set to 64 U/mL. Samples were diluted 100-20,000-fold.
Marker assays. Gelatinase and lactofenin were assayed by ELISA as described?2 Myeloperoxidase, for identification ofazurophi1 granules:' was measured by an ELSA using affinity-purified antimyeloperoxidase as catching antibody in a dilution of 1:100. Biotinylated polyclonal rabbit-antimyeloperoxidase antibodies (Dakopatts) were used as detecting antibody. Peroxidase-conjugated avidin (Dakopatts), diluted 1:2,000, was used next. Myeloperoxidase purified from isolated azurophil granules was used as standard. All buffers and procedures were as described for the NGAL ELISA. Plasma membranes were identified by HLA class I antigen in a mixed ELISA?4 Secretory vesicles were quantitated by latent alkaline phosphatase:s.26 ie, alkaline phosphatase only measurable in the presence of detergent (0.2% Triton X-100). Vitamin B,,-binding protein was measured as described by Gottlieb et al."
Electron microscopy. Isolated neutrophils were fixed in 2% paraformaldehyde, 0.05% glutaraldehyde or l% glutaraldehyde in 0.1 mol/L phosphate buffer (pH 7.4) for 4 hours at 4°C and were washed well in the same buffer containing 3% (wt/vol) sucrose. Some specimens were then incubated for peroxidase** to mark the peroxidase-positive azurophil gran~les.2~ The cells were pelleted and embedded in polyvinyl pyrrolidone sucrose, frozen, and stored in liquid nitrogen. Sections were cut on a Reichert-Jung (Buffalo, NY) ultracut E. The techniques used for preparing frozen thin sections have previously been described. 29 For single labeling of NGAL, anti-NGAL antibodies were used at a 100-fold dilution, followed by labeling with Protein A-IO gold (obtained from Dr G. Posthuma, Department ofcell Biology, University of Utrecht, Utrecht, Holland). Double-labeling experiments to localize NGAL and lactofenin or NGAL and gelatinase were performed using protein A, as described by Slot and Geuze." The NGAL antibody was used at a 1:lOO dilution, the lactofenin antibody at a 1 : I , O O O dilution, and the gelatinase antibody in a I : 100 dilution. The probes protein A-IO and A-20 were used at a 150 dilution. Nonimmune purified rabbit IgG was used asa control. For double-labeling of NGAL and lactofenin, rabbit antibody against NGAL was applied and labeled with Protein A-IO. Before the second antibody was added, 0.5% glutaraldehyde/phosphate-buffered saline was applied, followed by free protein A (0.05 mg/mL). An antibody to lactofenin (Accurate Chemical CO, Westbury, NY) was then added, followed by protein A-20. The grids were then stained with uranyl acetate and embedded in methylcellulose as described by Tokuyasu3' and modified by Griffiths et al.32 Double-labeling for NGAL and gelatinase was performed as described above, labeling NGAL with protein A-20 followed by labeling of gelatinase with protein A-IO.
Statistical ana/.vsis. For comparison of release of different peroxidase negative granule proteins, the one-sample t-test was used. P < .05 was considered significant. The intra-assay variation was determined by measuring the content of NGAL in the samples mentioned above and in a postnuclear supernatant from disrupted neutrophils. The variation was in average 6.8% (5.4% [56.1 pg/mL k 3.021, 7.9% [ 1.44 pg/mL k 0.1 l], and 7.1% [ 1.04 pg/mL f 0.071, respectively, n = 20 for every sample). The reproducibility was determined for the same three neutrophil samples. The inter-assay variation was in average 13.4% (1 1.6% [50.0 pg/mL f 5.81, 12.3% [ 1.72 pg/mL f 0.221, and 16.8% [ 1.09 pg/mL f 0.181, respectively, n = 10 for every sample). The accuracy of the ELISA was investigated by adding purified NGAL to the aforementioned samples, with subsequent measurement of the content of NGAL. In these experiments, the recovery of NGAL was 90'76, 9490, and 1 101, respectively.
RESULTS
NGAL
Subcellular localization of NGAL. The content of NGAL in subcellular fractions obtained after centrifugation of a postnuclear supernatant on two-layer Percoll density gradients" is shown in Fig 2. It is readily observed that NGAL colocalizes strictly with lactofemn, whereas gelatinase is peaking two fractions higher in the gradient. This indicates that NGAL is localized in specific granules partly separated from gelatinase. The ultrastructural localization of NGAL was investigated by electron microscopic immunocytochemistry. Figure 3a shows that NGAL is located in granules morphologically resembling specific granules, whereas the larger and more extracted azurophil granules do not contain label. This is confirmed in Fig 3b, where neutrophils were reacted for peroxidase before immunogold labeling. One technical problem encountered was the "spillage" of immunogold label out of granules resulting in poor exact localization of NGAL (Fig 3c) . This artifact has been encountered previously on frozen thin sections labeled for two other antigens of low molecular weight, d e f e n~i n s~~ (3.5 kD), and proteinase 334 (27 kD). With these antigens, it was possible to decrease the "leakage" by using high concentrations of glutaraldehyde. However, we were not able to completely immobilize NGAL even after fixation in 1% glutaraldehyde. Furthermore, the labeling of lactoferrin and gelatinase decreased significantly because of this fixation procedure, making double-label quantitation more difficult and less reliable. Double labeling for NGAL and lactofenin (Fig 4 and Table 1) showed colocalization in 69% of the labeled granules, whereas 15% were singly labeled for NGAL and 16% for lactofemn only. Double labeling for NGAL and gelatinase (Fig 5 and Table 1) showed that approximately 48% were double labeled, and 20% contained NGAL alone, whereas 32% labeled exclusively for gelatinase. Because ofthe technical limitations caused by the "spillage" of NGAL, these data on double labeling of NGAL with both lactofemn and gelatinase are of limited value and should be interpreted cautiously. For this reason, the immunogold labeling by itself does not allow firm conclusions to be drawn regarding the distribution of NGAL, although the colocalization of NGAL with lactoferrin in 70% of peroxidase negative granules is in line with the subcellular fractionation data, that clearly show NGAL to be a component of specific granules.
Subcellular localization of lhe NGAL/gelatinase complex.
Considering the difficulties to immobilize NGAL in fixed frozen thin sections, the observed colocalization of NGAL and gelatinase in 50% of peroxidase-negative granules (Table l), is in good agreement with the data that can be deduced from the strict colocalization of NGAL and lactoferrin in subcellular fractions and the previously observed colocalization of lactofenin and gelatinase in 60% of peroxidase negative granules." The granules that contain both lactofemn and gelatinase have been shown to have a density between granules containing lactofemn only and granules containinggelatinase only. It is tempting to hypothesize that NGAL and gelatinase tend to be covalently complexed to each other in these granules, or in other words, that the subcellular distribution profile of the NGAL/gelatinase complex should be located between the profiles of NGAL and gelatinase. To test this hypothesis, an ELISA for the NGAL/ gelatinase complex was developed using anti-NGAL antibodies as catching antibodies and biotinylated antigelatinase antibodies as detecting antibodies. To verify that the assay was specific for the complex, samples of purified gelatinase (which is a mixture of uncomplexed gelatinase and NGAL/gelatinase complex9) were reduced by dithiotreitol before measurement. This resulted in disappearance of 95% of the reactivity in the NGAL/gelatinase complex ELISA, whereas the measurements of gelatinase by the gelatinase ELISA was only reduced by 18%. The measurement of NGAL by the NGAL ELISA was actually enhanced by 97% upon reduction of the purified gelatinase. This enhancement was not observed when purified NGAL was reduced before measurement, indicating that the complex formation of NGAL with gelatinase might sterically inhibit the measurement of NGAL. The almost complete disappearance of reactivity in the NGAL/gelatinase complex ELISA upon reduction confirms the specificity ofthe assay for the complex. Figure 6 shows the distribution profile of NGAL, of the NGAL/gelatinase complex, and of gelatinase. As suspected, the profile of the NGAL/gelatinase complex corresponds exactly to the overlap between the profiles of gelatinase and NGAL.
Mobilization of peroxidase-negative granule subpopulations. We are now able to test the hypothesis that peroxidase-negative granules comprise a continuum from granules high in lactofemn but devoid of gelatinase, and scarcely mobilized by inflammatory mediators to granules high in gelatinase and low in lactofemn and more readily mobilized. Neutrophils in suspension were stimulated with various secretagogues and the release of NGAL and the specific granule markers lactofenin and vitamin B12-binding protein was measured and compared with the release of the NGAL/gelatinase complex and of gelatinase. 100 U/mL recombinant granulocyte macrophage colony stimulating factor (GM-CSF); 2 rg/mL phorbol myristate acetat (PMA); 1 pmol/L lonomycin (lono). Error bars represent SD of six experiments with different donors. Under all conditions (apart from at CC), the release of gelatinase was significantly higher than release of the NGAL/gelatinase complex, which again was significantly higher than release of NGAL, lactofenin, and vitamin B,,-binding protein (P < .05, one sample t-test). There was no significant difference between release of NGAL and vitamin B,,-binding protein, whereas the release of lactoferrin was slightly but significantly less than both NGAL and vitamin' Bl2-binding protein under most conditions. This is possibly because of the tendency of lactoferrin to stick to plasma membranes after exocytosis.
ments. The release of vitamin Blz-binding protein and NGAL was identical, and the release of lactofemn was very similar although slightly lower. This further validates the allocation of these proteins to the same subcellular compartment, the specific granules. As mentioned, the release of NGAL slightly exceeded the release of lactofemn most notably when potent secretagogues were used. This is likely because of underestimation of lactofemn release, because lactofenin tends to stick to plasma membranes after exocytosis, and therefore, is measured in the cell pellet rather than in the supernatant. The release of gelatinase was under all conditions significantly higher than release of the NGAL/gelatinase complex, which again was significantly higher than release of lactofemn, NGAL, and vitamin B12-binding protein (Fig 7) . This implies that the different subpopulations within peroxidase negative granules are differentially mobilized.
DISCUSSION
We have developed an ELISA for NGAL, which is specific, sensitive, and reproducible. This assay has enabled us to determine the subcellular localization of NGAL in human neutrophils. We found that NGAL colocalizes completely with lactofemn when measured in subcellular fractions. Double-labeling immunogold electron microscopy also indicated that NGAL is a component of specific granules, because NGAL mainly colocalized with lactofemn. Because of leakage of NGAL out of granules, this technique only permitted observation of colocalization of NGAL and lactofemn in 70% of peroxidase-negative granules. We believe that this is an underestimation, because complete colocalization was observed by subcellular fractionation. The release of NGAL induced by a variety of stimuli was similar to the release oflactofemn and vitamin BIZ-binding protein, and we therefore conclude that NGAL is a novel matrix protein of specific granules. Allen et aP5 have previously published the amino-terminal amino acid sequence of a 24-kD protein, which was shown to bind a radioiodinated photoactivatable derivative of FMLPK. The 23 amino acids reported correspond to residues number 4 to 27 in the sequence of NGAL, and thus, the 24-kD protein is identical to NGAL. We have recently confirmed the ability of NGAL to bind a similar derivative of FMLP (Sengebv et al, submitted). Based on this ability to bind FMLP, Allen et al suggested, in line with our findings, that the protein resides in specific granules, although the authors did not consider the existence of gelatinase granules.
NGAL is the human analogue of the rat protein a2-microglobulin-related protein and the mouse protein 2 4~3 .~3~~~~~ Both ofthese proteins have been identified solely by molecular cloning and their functions and subcellular localizations are unknown. There are several other known members of the lipocalin family, of which prostaglandin-D synthase and a,-microglobulin have the highest degree of similarity with NGAL. Apart from prostaglandin-D synthase, which is membrane associated in neurons in human brain, most other lipocalins are liberated constitutively to body NGAL differs in this respect, because it is packed in specialized granules (specific granules) in a high concentration and only liberated from the neutrophil by potent stimuli. Weak stimulation of the neutrophil with inflammatory mediators like FMLP, platelet activating factor, and leukotriene B4 results in complete exocytosis of secretory vesicles, an organelle recently described in human neutrophils, and identified by latent alkaline phosphata~e.~'.~~ Exocytosis of this compartment results in upregulation of important membrane proteins like Mac-1 and FMLP recept o r~~' ,~~ (Sengelsv et al, submitted) . The same stimuli furthermore result in release of 15% to 25% of gelatinase from gelatinase granules.16 This is likely to play a role for diapedesis ofthe neutrophil. On the other hand, very little NGAL is released by these weak stimulations, and only the fully activated neutrophil liberates substantial amounts of NGAL along with reactive oxygen species and other bactericidal products. In correspondence with the ability of NGAL to bind FMLP in vitro, a potential role of the protein in vivo could be the binding of small lipophilic inflammatory mediators, not only FMLP, but also platelet activating factor, leukotriene B4, and perhaps lipopolysaccharide. In this way it may serve as a feedback inhibitor of the inflammatory response. It therefore seems teleologically wise to pack NGAL in granules that are only exocytosed, when the cell is fully activated, to prevent early and inappropriate inhibition of the neutrophil response to inflammatory mediators. The functional significance of complex formation between NGAL and gelatinase is not known. We have not been able to show any modulatory actions of NGAL on the activation or gelatinolytic activity of gelatinase (unpublished observation, February 1993). This is in accordance with the findings of Triebel et al. 38 The subcellular localization ofthe NGAL/gelatinase complex between the distribution profiles of NGAL and gelatinase respectively confirms the existence of subpopulations within peroxidase negative granules. This allows us to document that peroxidase-negative granules as previously p r~p o s e d~, '~, '~.~~ exist as a continuum from granules high in lactofenin and NGAL and hardly mobilized by inflammatory mediators to granules enriched in gelatinase but containing very little lactoferrin and mobilized more extensively upon stimulation. The functional significance of this finding can only be fully appreciated when more effective methods for separating these granule subpopulations are developed. This will allow analysis of differences in both matrix and membrane proteins between these subsets, other than the marker proteins now identified, NGAL, gelatinase, and the NGAL/gelatinase complex. The recognition of this granule heterogeneity has important consequences for the understanding of how targeting of proteins to such a variety of granules can be regulated during myelopoiesis.
